Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? von Odabas, Hatice, Dogan, Akif, Ozcelik, Melike, Yildirim, Sedat, Ozkerim, Ugur, Turan, Nedim, Yildirim, Mahmut Emre, Gumus, Mahmut

Volltext

The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy von Yildirim, Sedat, Dogan, Akif, Akdag, Goncagul, Yüksel Yasar, Zeynep, Bal, Hamit, Kinikoglu, Oguzcan, Oksuz, Sila, Ozkerim, Ugur, Tunbekici, Salih, Yildiz, Hacer Sahika, Alan, Ozkan, Coban Kokten, Sermin, Isik, Deniz, Surmeli, Heves, Basoglu, Tugba, Sever, Ozlem Nuray, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim

Volltext

Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer? von Akdag, Goncagul, Isik, Deniz, Dogan, Akif, Yildirim, Sedat, Kinikoglu, Oguzcan, Topal, Alper, Oksuz, Sila, Turkoglu, Ezgi, Surmeli, Heves, Basoglu, Tugba, Sever, Ozlem Nuray, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim

Volltext

Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis von Yildirim, Sedat, Alan, Ozkan, Yuksel Yasar, Zeynep, Kaya, Tugba, Akdag, Goncagul, Kinikoglu, Oguzcan, Gecmen, Gonca Gul, Yasar, Alper, Isik, Deniz, Surmeli, Heves, Basoglu, Tugba, Sever, Ozlem Nuray, Yildirim, Mahmut Emre, Odabas, Hatice, Turan, Nedim

Volltext

The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas von Aydin, Dincer, Kefeli, Umut, Ozcelik, Melike, Erdem, Gokmen Umut, Sendur, Mehmet Ali, Yildirim, Mahmut Emre, Oven, Basak Bala, Bilici, Ahmet, Gumus, Mahmut

Volltext

Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study von Akdag, Goncagul, Alan, Özkan, Dogan, Akif, Yildirim, Sedat, Kinikoglu, Oguzcan, Batu, Aziz, Kudu, Emre, Geçmen, Gonca Gül, Isik, Deniz, Sever, Ozlem Nuray, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim

Volltext

Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab von Kudu, Emre, Akdag, Goncagul, Yildirim, Mahmut Emre

Volltext

Evaluation of the effectiveness of colorectal cancer screening intervention von Turan, Guven, Turan, Merve, Ikiisik, Hatice, Yildirim, Mahmut Emre, Cakir, Mustafa, Maral, Isil

Volltext

Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer von Kınıkoğlu, Oğuzcan, Odabas, Hatice, Altıntaş, Yunus Emre, Yıldız, Anıl, Çakan, Burçin, Akdağ, Goncagül, Yıldırım, Sedat, Bal, Hamit, Kaya, Tuğba, Tünbekici, Salih, Işık, Deniz, Başoğlu, Tuğba, Yıldırım, Mahmut Emre, Turan, Nedim

Volltext

Malignancies in individuals living with HIV/AIDS von Kaya, Bülent, Kaya, Sibel Doğan, Öcal, Gülfem Akengin, Yıldırım, Mahmut Emre, Yılmaz, Güven

Volltext

Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience von Akdag, Goncagul, Alan, Ozkan, Dogan, Akif, Yuksel, Zeynep, Yildirim, Sedat, Kinikoglu, Oguzcan, Kudu, Emre, Surmeli, Heves, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim

Volltext

Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer von Ay, Seval, Ozyukseler, Deniz Tataroglu, Dulgar, Ozgecan, Basak, Mustafa, Yildirim, Mahmut Emre, Gumus, Mahmut

Volltext

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC von Yildirim, Mahmut Emre, Karaca, Mustafa, Artac, Mehmet, Cicin, Irfan, Geredeli, Caglayan, Alacacioglu, Ahmet, Tanrikulu Simsek, Eda, Bilici, Ahmet, Harputluoglu, Hakan, Ozcelik, Melike, Bozkurt, Oktay, Yuksel, Sinemis, Tural, Deniz, Sakin, Abdullah, Cil, Timucin, Oven, Basak Bala, Dane, Faysal, Cevik, Duygu, Gumus, Mahmut, Isikdogan, Abdurrahman

Volltext

A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients von Yildirim, Sedat, Dogan, Akif, Akdag, Goncagul, Cavdar, Eyyup, Kinikoglu, Oguzcan, Oksuz, Sila, Yildiz, Hacer Sahika, Kucukoz Uzun, Aysun, Isik, Deniz, Surmeli, Heves, Basoglu, Tugba, Sever, Ozlem Nuray, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim

Volltext

Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wi̇ld-type patients treated with biologics first-line metastatic colorectal cancer von Kefeli, Umut, Arslan, Cagatay, Yildirim, Mahmut Emre, Isikdogan, Abdurrahman, Karadurmus, Nuri, Karabulut, Bulent, Cubukcu, Erdem, Cicin, Irfan, Yalçin, Şuayib, Turk, Haci M., Bilir, Cemil, Karaca, Mustafa, Artac, Mehmet, Sendur, Mehmet Nahit, Alacacioglu, Ahmet, Simsek, Eda Tanrikulu, Dane, Faysal, Bilici, Ahmet, Cevik, Duygu, Gumus, Mahmut

Volltext

Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older von Isik, Deniz, Alan, Özkan, Akdağ, Goncagül, Yildirim, Sedat, Kınıkoğlu, Oğuzcan, Altintas, Yunus Emre, Turkoglu, Ezgi, Surmeli, Heves, Basoglu, Tugba, Sever, Ozlem Nuray, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim

Volltext

Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data von AKDAĞ, Goncagül, ALAN, Özkan, DOĞAN, Akif, YILDIRIM, Sedat, KINIKOĞLU, Oğuzcan, MAJIDOVA, Nargiz, BAYOĞLU, İbrahim Vedat, KAPAR, Caner, ERÇİN, Eda, ALACA TOPÇU, Zeynep, GULIYEV, Murad, IŞIK, Deniz, SEVER, Özlem Nuray, ODABAŞ, Hatice, YILDIRIM, Mahmut Emre, TURAN, Nedim

Volltext

Cytoreductive surgery for intestinal cancer patients metastatic to the adnexal presenting as primary ovarian cancer von Arik, Zafer, Dizdar, Omer, Yildirim, Mahmut Emre, Ozgu, Emre, OZ, Murat, Terzioglu, Serdar gokay, Gungor, Tayfun

Volltext

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group von Erol, Cihan, Nahit Sendur, Mehmet, Bilgetekin, Irem, Garbioglu, Duygu, Hamdard, Jamshid, Akbas, Sinem, Hizal, Mutlu, Arslan, Cagatay, Sevinc, Alper, Kucukarda, Ahmet, Erdem, Dilek, Kahraman, Seda, Cakir, Emre, Demirkiran, Aykut, On, Sercan, Dogan, Izzet, Erdogan, Atike, Koca, Sinan, Kubilay, Pinar, Eren, Orhan, Cilbir, Ebru, Celik, Emir, Araz, Murat, Ozyukseler, Deniz, Yildirim, Mahmut, Bahceci, Aykut, Taskaynatan, Halil, Oyman, Abdilkerim, Deniz, Gulhan, Menekse, Serkan, Kut, Engin, Gulmez, Ahmet, Sakin, Abdullah, Nayir, Erdinc, Acar, Ramazan, Sen, Erdem, Inal, Ali, Turhal, Serdar, Kaya, Ali, Paydas, Semra, Tastekin, Didem, Hacibekiroglu, Ilhan, Cincin, Irfan, Bilici, Ahmet, Mandel, Nil, Dede, Didem, Akinci, Muhammed, Oksuzoglu, Berna, Uncu, Dogan, Yalcin, Bulent, Artac, Mehmet

Volltext

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC von Yildirim, Mahmut Emre, Karadurmuş, Nuri, Ökten, İlker Nihat, Türk, Hacı Mehmet, Urakçı, Zuhat, Arslan, Çağatay, Çelik, Sinemis, Dane, Faysal, Şendur, Mehmet Ali Nahit, Bilir, Cemil, Karabulut, Bülent, Cicin, İrfan, Çubukçu, Erdem, Karaca, Mustafa, Ozcelik, Melike, Artaç, Mehmet, Tanrikulu, Eda, Alacacioglu, Ahmet, Açıkgöz, Özgür, Öven, Başak, Geredeli, Çağlayan, Çil, Timucin, Harputluoğlu, Hakan, Kefeli, Umut, Bozkurt, Oktay, Tural, Deniz, Sakin, Abdullah, Yalçın, Şuayip, Gumus, Mahmut

Volltext